Add‐on felbamate vs placeboSeizure frequency reduction (3‐month blinded evaluation period) · people with drug‐resistant focal epilepsy1 finding from 1 reviewFelbamate add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 172 participantsVery low